Trudy G. Oliver

Trudy G. Oliver

Auto-generated profile, based on publicly available information

Trudy G. Oliver

Department of Pharmacology and Cancer Biology, Duke University, Durham, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Cancer Cell
Verified
Journal Article
Closed access
GMGurkan Mollaoglu
Gurkan Mollaoglu
MGMatthew R. Guthrie
Matthew R. Guthrie
SBStefanie Böhm
Stefanie Böhm
JBJohannes Brägelmann
Johannes Brägelmann
ICIsmail Can
Ismail Can
TOTrudy G. Oliver
Trudy G. Oliver

30 May 2020 in Cancer Cell
Verified
Journal Article
Closed access
AIAbbie S. Ireland
Abbie S. Ireland
AMAlexi M. Micinski
Alexi M. Micinski
DKDavid W. Kastner
David W. Kastner
BGBingqian Guo
Bingqian Guo
SWSarah J. Wait
Sarah J. Wait
TOTrudy G. Oliver
Trudy G. Oliver

17 February 2020 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
CSC. Allison Stewart
C. Allison Stewart
CGCarl M. Gay
Carl M. Gay
YXYuanxin Xi
Yuanxin Xi
SSSanthosh Sivajothi
Santhosh Sivajothi
VSV. Sivakamasundari
V. Sivakamasundari
LBLauren Averett Byers
Lauren Averett Byers

30 May 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TOTrudy G. Oliver
Trudy G. Oliver
LGLinda L. Grasfeder
Linda L. Grasfeder
ACAudra L. Carroll
Audra L. Carroll
CKConstanze Kaiser
Constanze Kaiser
CGChristine L. Gillingham
Christine L. Gillingham
RWRobert J. Wechsler-Reya
Robert J. Wechsler-Reya
Cerebellar granule cells are the most abundant neurons in the brain, and granule cell precursors (GCPs) are a common target of transformation in the pediatric brain tumor medulloblastoma. Proliferation of GCPs is regulated by the secreted signaling molecule Sonic hedgehog (Shh), but the mechanisms by which Shh controls proliferation of GCPs remain inadequately understood. We used DNA microarrays to identify targets of Shh in these cells and found that Shh activates a program of transcription that promotes cell cycle entry and DNA replication. Among the genes most robustly induced by Shh are cyclin D1 and N-myc. N-myc transcription is induced in the presence of the protein synthesis inhibitor cycloheximide, so it appears to be a direct target of Shh. Retroviral transduction of N-myc into GCPs induces expression of cyclin D1, E2F1 , and E2F2 , and promotes proliferation. Moreover, dominant-negative N-myc substantially reduces Shh-induced proliferation, indicating that N-myc is required for the Shh response. Finally, cyclin D1 and N-myc are overexpressed in murine medulloblastoma. These findings suggest that cyclin D1 and N-myc are important mediators of Shh-induced proliferation and tumorigenesis.

1 February 2018 in Translational Lung Cancer Research
Verified
Journal Article
Closed access
PDF file
WZWei Zhang
Wei Zhang
LGLuc Girard
Luc Girard
YZYu-An Zhang
Yu-An Zhang
THTomohiro Haruki
Tomohiro Haruki
MPMahboubeh Papari-Zareei
Mahboubeh Papari-Zareei
AGAdi F. Gazdar
Adi F. Gazdar
Background: Small cell lung cancer (SCLC) is a deadly, high grade neuroendocrine (NE) tumor without recognized morphologic heterogeneity. However, over 30 years ago we described a SCLC subtype with “variant” morphology which did not express some NE markers and exhibited more aggressive growth. Methods: To quantitate NE properties of SCLCs, we developed a 50-gene expression-based NE score that could be applied to human SCLC tumors and cell lines, and genetically engineered mouse (GEM) models. We identified high and low NE subtypes of SCLC in all of our sample types, and characterized their properties. Results: We found that 16% of human SCLC tumors and 10% of SCLC cell lines were of the low NE subtype, as well as cell lines from the GEM model. High NE SCLC lines grew as non-adherent floating aggregates or spheroids while Low NE lines had morphologic features of the variant subtype and grew as loosely attached cells. While the high NE subtype expressed one of the NE lineage master transcription factors ASCL1 or NEUROD1, together with NKX2-1, the entire range of NE markers, and lacked expression of the neuronal and NE repressor REST, the low NE subtype had lost expression of most NE markers, ASCL1, NEUROD1 and NKX2-1 and expressed REST. The low NE subtype had undergone epithelial mesenchymal transition (EMT) and had activated the Notch, Hippo and TGFβ pathways and MYC oncogene . Importantly, the high and low NE group of SCLC lines had similar gene expression profiles as their SCLC tumor counterparts. Conclusions: SCLC tumors and cell lines can exhibit distinct inter-tumor heterogeneity with respect to expression of NE features. Loss of NE expression results in major alterations in morphology, growth characteristics, and molecular properties. These findings have major clinical implications as the two subtypes are predicted to have very different responses to targeted therapies.

15 May 2005 in Development
Verified
Journal Article
Open access
PDF file
TOTrudy G. Oliver
Trudy G. Oliver
TRTracy Ann Read
Tracy Ann Read
JKJessica D. Kessler
Jessica D. Kessler
AMAnriada Mehmeti
Anriada Mehmeti
JWJonathan F. Wells
Jonathan F. Wells
RWRobert J. Wechsler-Reya
Robert J. Wechsler-Reya
Medulloblastoma is the most common malignant brain tumor in children. It is thought to result from the transformation of granule cell precursors (GCPs) in the developing cerebellum, but little is known about the early stages of the disease. Here, we identify a pre-neoplastic stage of medulloblastoma in patched heterozygous mice, a model of the human disease. We show that pre-neoplastic cells are present in the majority of patched mutants, although only 16% of these mice develop tumors. Pre-neoplastic cells, like tumor cells, exhibit activation of the Sonic hedgehog pathway and constitutive proliferation. Importantly, they also lack expression of the wild-type patched allele, suggesting that loss of patched is an early event in tumorigenesis. Although pre-neoplastic cells resemble GCPs and tumor cells in many respects, they have a distinct molecular signature. Genes that mark the pre-neoplastic stage include regulators of migration, apoptosis and differentiation, processes crucial for normal development but previously unrecognized for their role in medulloblastoma. The identification and molecular characterization of pre-neoplastic cells provides insight into the early steps in medulloblastoma formation, and may yield important markers for early detection and therapy of this disease.